158 related articles for article (PubMed ID: 36907174)
1. Chromosome 18 Loss of Heterozygosity in Small Intestinal Neuroendocrine Tumours: Multi-Omic and Tumour Composition Analyses.
Waterfield S; Yousefi P; Webster A; Relton C; Thirlwell C; Suderman M
Neuroendocrinology; 2023; 113(9):915-923. PubMed ID: 36907174
[TBL] [Abstract][Full Text] [Related]
2. Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors.
Byun S; Affolter KE; Snow AK; Curtin K; Cannon AR; Cannon-Albright LA; Thota R; Neklason DW
Sci Rep; 2021 Jun; 11(1):12303. PubMed ID: 34112938
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
[TBL] [Abstract][Full Text] [Related]
4. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
[TBL] [Abstract][Full Text] [Related]
5. Genetics and epigenetics in small intestinal neuroendocrine tumours.
Stålberg P; Westin G; Thirlwell C
J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
[TBL] [Abstract][Full Text] [Related]
6. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
Scarpa A
Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
[TBL] [Abstract][Full Text] [Related]
7. Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours.
Kajiura K; Takizawa H; Morimoto Y; Masuda K; Tsuboi M; Kishibuchi R; Wusiman N; Sawada T; Kawakita N; Toba H; Yoshida M; Kawakami Y; Naruto T; Imoto I; Tangoku A; Kondo K
Lung Cancer; 2017 Sep; 111():116-123. PubMed ID: 28838380
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment.
Tanno L; Naheed S; Dunbar J; Tod J; Lopez MA; Taylor J; Machado M; Green B; Ashton-Key M; Chee SJ; Wood O; Pearce NW; Thomas GJ; Friedmann PS; Cave J; Ottensmeier CH
Neuroendocrinology; 2022; 112(4):370-383. PubMed ID: 34157710
[TBL] [Abstract][Full Text] [Related]
9. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors.
Zhang Z; Mäkinen N; Kasai Y; Kim GE; Diosdado B; Nakakura E; Meyerson M
Genes Chromosomes Cancer; 2020 Sep; 59(9):535-539. PubMed ID: 32291827
[TBL] [Abstract][Full Text] [Related]
10. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.
Walter D; Harter PN; Battke F; Winkelmann R; Schneider M; Holzer K; Koch C; Bojunga J; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Waidmann O
Sci Rep; 2018 Feb; 8(1):3811. PubMed ID: 29491456
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
[TBL] [Abstract][Full Text] [Related]
13. Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
Epigenetics; 2014 Jul; 9(7):987-97. PubMed ID: 24762809
[TBL] [Abstract][Full Text] [Related]
14. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant
Fotouhi O; Ghaderi M; Wang N; Zedenius J; Kjellman M; Xu D; Juhlin CC; Larsson C
Epigenetics; 2019 Dec; 14(12):1224-1233. PubMed ID: 31322481
[TBL] [Abstract][Full Text] [Related]
16. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
[TBL] [Abstract][Full Text] [Related]
17. Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
Van Den Heede K; Chidambaram S; Van Slycke S; Brusselaers N; Warfvinge CF; Ohlsson H; Nordenström E; Almquist M
Br J Surg; 2022 Feb; 109(2):191-199. PubMed ID: 34941998
[TBL] [Abstract][Full Text] [Related]
18. Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours.
Rico K; Duan S; Pandey RL; Chen Y; Chakrabarti JT; Starr J; Zavros Y; Else T; Katona BW; Metz DC; Merchant JL
BMJ Open Gastroenterol; 2021 Nov; 8(1):. PubMed ID: 34750164
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
20. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
